Health Line International Corp., a Numantec company, strengthens our portfolio with the acquisition of DualCap®, a well-established antimicrobial cap for needle-free access ports used in vascular access and infusion therapy procedures. This addition supports infection-prevention protocols, streamlines clinical workflows, and complements our patented insertion technology that replaces the traditional Seldinger technique.
The product line further strengthens Numantec’s portfolio of vascular access and infusion therapy solutions. This acquisition creates meaningful synergies, positioning Numantec to accelerate the expansion of the DualCap® product line across Europe, while leveraging the established DualCap® US customer base to cross-sell its broader infusion portfolio.
1 Comment
An exciting development that signals meaningful innovation in healthcare delivery and technology. Strategic acquisitions like this can accelerate smarter, more integrated solutions for patients and providers alike.